Regenxbio (RGNX) Total Non-Current Liabilities (2015 - 2026)
Regenxbio's Total Non-Current Liabilities was $314.37 million in Q2 2026, down 14.3% from $366.68 million a year earlier and down 1.8% from the prior quarter.
Powered by 
Analysis
Regenxbio (RGNX) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends
At the end of FY2025, Total Non-Current Liabilities at Regenxbio came in at $349.66 million, up 72.5% from FY2024.
- Total Non-Current Liabilities shows a five-year compound annual growth rate of 17.6% (FY2020 to FY2025).
- In earlier years, Total Non-Current Liabilities was $202.7 million in FY2024 (-4.6%), $212.49 million in FY2023 (-3.1%), $219.24 million in FY2022 (+1.8%) and $215.4 million in FY2021 (+38.6%).
- The Q2 2026 figure marks the lowest quarterly Total Non-Current Liabilities since Q1 2025.
- Compared with a year earlier, Total Non-Current Liabilities was higher in five of the last eight quarters, with growth averaging 39.1%.
- The best year-over-year quarter for Total Non-Current Liabilities over five years was Q2 2025 (growth of 107.7%); the worst was Q3 2024 (a decline of 15.3%).
- Per Business Quant data, RGNX's Total Non-Current Liabilities in the three quarters before Q2 2026 was $320.19 million (Q1 2026), $349.66 million (Q4 2025) and $363.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 60.81 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 102.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 117.60 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 79.95 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 76.12 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 36.05 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 96.04 Bn |
| 10 | Regenxbio | 418.33 Mn | -341.95 Mn | - | 314.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 314.37 Mn |
| Dec 31, 2025 | 349.66 Mn |
| Sep 30, 2025 | 363.10 Mn |
| Jun 30, 2025 | 366.68 Mn |
| Mar 31, 2025 | 204.93 Mn |
| Dec 31, 2024 | 202.70 Mn |
| Sep 30, 2024 | 179.07 Mn |
| Jun 30, 2024 | 176.51 Mn |
| Mar 31, 2024 | 190.36 Mn |
| Dec 31, 2023 | 212.49 Mn |
| Sep 30, 2023 | 211.40 Mn |
| Jun 30, 2023 | 203.15 Mn |
| Mar 31, 2023 | 199.33 Mn |
| Dec 31, 2022 | 219.24 Mn |
| Sep 30, 2022 | 208.22 Mn |
| Jun 30, 2022 | 200.23 Mn |
| Mar 31, 2022 | 205.51 Mn |
| Dec 31, 2021 | 215.40 Mn |
| Sep 30, 2021 | 194.18 Mn |
| Jun 30, 2021 | 177.57 Mn |
API Access
Regenxbio Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();